Since many current therapeutic efforts are aimed at generating an increase in Mtb-specific IFNγ-producing Th1 cells, we next tested the ability of DCs to re-boost newly recruited CD4+ T cells in acute and chronic granulomas. Here, CD4 is linked to Granuloma.